Anixa Biosciences, Inc.
Anixa Biosciences, Inc. (ANIX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ANIX · as of Jun 9, 2026
Activity summary
Buy transactions
7
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Anixa Biosciences, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ANIX insider buying and selling by quarter
ANIX insider selling · ANIX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ANIX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ANIX executive sell shares · ANIX board member insider trading · ANIX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 28, 2026 | Baskies Arnold M Director | Purchase | 10,000 | $30K | Form 4 |
| Dec 15, 2025 | Titterton Lewis H jr Director | Option | 16,000 | $47K | Form 4 |
| Oct 30, 2025 | KUMAR AMIT CEO | Option | 200,000 | $584K | Form 4 |
| Oct 30, 2025 | KUMAR AMIT CEO | Other | 169,439 | $688K | Form 4 |
| Jul 31, 2025 | Titterton Lewis H jr Director | Purchase | 10,000 | $31K | Form 4 |
| Jul 30, 2025 | KUMAR AMIT CEO | Purchase | 5,000 | $16K | Form 4 |
| Jul 18, 2025 | Baskies Arnold M Director | Purchase | 5,000 | $17K | Form 4 |
| Jul 11, 2025 | Titterton Lewis H jr Director | Purchase | 10,000 | $31K | Form 4 |
| Jul 11, 2025 | KUMAR AMIT CEO | Purchase | 5,000 | $16K | Form 4 |
| Jun 4, 2025 | KUMAR AMIT CEO | Purchase | 10,000 | $29K | Form 4 |
| Jan 28, 2025 | Baskies Arnold M Director | Purchase | 5,000 | $14K | Form 4 |
| Jan 24, 2025 | Titterton Lewis H jr Director | Purchase | 1,000 | $3K | Form 4 |
| Jan 23, 2025 | Titterton Lewis H jr Director | Purchase | 2,000 | $6K | Form 4 |
| Jan 22, 2025 | Titterton Lewis H jr Director | Purchase | 2,000 | $6K | Form 4 |
| Jan 21, 2025 | Titterton Lewis H jr Director | Purchase | 6,000 | $16K | Form 4 |
| Jan 17, 2025 | Titterton Lewis H jr Director | Purchase | 10,000 | $26K | Form 4 |
| Jan 15, 2025 | KUMAR AMIT CEO | Purchase | 43,000 | $96K | Form 4 |
| Jan 15, 2025 | Catelani Michael President, COO, & CFO | Purchase | 9,289 | $20K | Form 4 |
| Oct 22, 2024 | Titterton Lewis H jr Director | Option | 16,000 | $41K | Form 4 |
| Jul 31, 2024 | Titterton Lewis H jr Director | Purchase | 5,580 | $18K | Form 4 |
| Jul 30, 2024 | Titterton Lewis H jr Director | Purchase | 21,646 | $66K | Form 4 |
| Jul 26, 2024 | Titterton Lewis H jr Director | Purchase | 7,700 | $23K | Form 4 |
| Jul 25, 2024 | Titterton Lewis H jr Director | Purchase | 796 | $2K | Form 4 |
| Jul 26, 2024 | Baskies Arnold M Director | Purchase | 5,000 | $15K | Form 4 |
| Jun 14, 2024 | Titterton Lewis H jr Director | Purchase | 4,000 | $11K | Form 4 |
Catelani Michael
President, COO, & CFO
Date
Jan 15
Shares
9,289
Price
$2.15
Value
$20K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ANIX insider trading
ANIX insider trades
Anixa Biosciences, Inc. (ANIX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including KUMAR AMIT (CEO), Titterton Lewis H jr (Director), Baskies Arnold M (Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. ANIX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Anixa Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ANIX insider trading · 5 questionsThe insiders of Anixa Biosciences, Inc. (ANIX) include executives and directors such as KUMAR AMIT (CEO), Titterton Lewis H jr (Director), Baskies Arnold M (Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026